-
Je něco špatně v tomto záznamu ?
Double germline mutations in the RET Proto-oncogene in MEN 2A and MEN 2B kindreds
Dvorakova S, Vaclavikova E, Ryska A, Cap J, Vlcek P, Duskova J, Kodetova D, Holub V, Novak Z, Bendlova B.
Jazyk angličtina Země Německo
Grantová podpora
NR7806
MZ0
CEP - Centrální evidence projektů
Digitální knihovna NLK
Plný text - Část
Zdroj
- MeSH
- alely MeSH
- dospělí MeSH
- exony genetika MeSH
- financování organizované MeSH
- kohortové studie MeSH
- lidé středního věku MeSH
- lidé MeSH
- mladiství MeSH
- mnohočetná endokrinní neoplazie typ 2A genetika MeSH
- mnohočetná endokrinní neoplazie typ 2B genetika MeSH
- nádory štítné žlázy genetika MeSH
- protoonkogenní proteiny c-ret chemická syntéza MeSH
- rodokmen MeSH
- substituce aminokyselin MeSH
- zárodečné mutace MeSH
- Check Tag
- dospělí MeSH
- lidé středního věku MeSH
- lidé MeSH
- mladiství MeSH
- mužské pohlaví MeSH
- ženské pohlaví MeSH
Medullary thyroid carcinoma (MTC) is a rare form of thyroid cancer representing about 10% of all thyroid malignancies. It occurs mostly as a sporadic tumor or in association with autosomal dominant inherited cancer syndromes--multiple endocrine neoplasia (MEN) types 2A and 2B and familial MTC. Germline mutations in exons 8, 10, 11, 13, 14, 15 and 16 of the RET proto-oncogene are found in most of the familial cases. There are only a few published data reporting multiple germline mutations in the RET proto-oncogene. We have detected double germline mutations in 2 different exons on the same RET allele in two MEN 2 families. In the MEN 2A family, double germline mutation in exons 10 (Cys620Phe) and 13 (Tyr791Phe) was detected. In the MEN 2B family, beside the classical germline mutation in exon 16 (Met918Thr) a second germline mutation in exon 13 (Tyr791Phe) was found. This study revealed that MEN 2 syndromes can also be caused by double germline mutations in the RET proto-oncogene and these families can be added to small worldwide cohort of families with multiple germline mutations.
- 000
- 00000naa 2200000 a 4500
- 001
- bmc07523563
- 003
- CZ-PrNML
- 005
- 20130819124313.0
- 008
- 090520s2006 gw e eng||
- 009
- AR
- 040 __
- $a ABA008 $b cze $c ABA008 $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a gw
- 100 1_
- $a Dvořáková, Šárka $7 xx0080456
- 245 10
- $a Double germline mutations in the RET Proto-oncogene in MEN 2A and MEN 2B kindreds / $c Dvorakova S, Vaclavikova E, Ryska A, Cap J, Vlcek P, Duskova J, Kodetova D, Holub V, Novak Z, Bendlova B.
- 314 __
- $a Institute of Endocrinology, Department of Endokrinology, Prague 1, Czech Republic. sarka@obloha.cz
- 520 9_
- $a Medullary thyroid carcinoma (MTC) is a rare form of thyroid cancer representing about 10% of all thyroid malignancies. It occurs mostly as a sporadic tumor or in association with autosomal dominant inherited cancer syndromes--multiple endocrine neoplasia (MEN) types 2A and 2B and familial MTC. Germline mutations in exons 8, 10, 11, 13, 14, 15 and 16 of the RET proto-oncogene are found in most of the familial cases. There are only a few published data reporting multiple germline mutations in the RET proto-oncogene. We have detected double germline mutations in 2 different exons on the same RET allele in two MEN 2 families. In the MEN 2A family, double germline mutation in exons 10 (Cys620Phe) and 13 (Tyr791Phe) was detected. In the MEN 2B family, beside the classical germline mutation in exon 16 (Met918Thr) a second germline mutation in exon 13 (Tyr791Phe) was found. This study revealed that MEN 2 syndromes can also be caused by double germline mutations in the RET proto-oncogene and these families can be added to small worldwide cohort of families with multiple germline mutations.
- 650 _2
- $a financování organizované $7 D005381
- 650 _2
- $a mladiství $7 D000293
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a alely $7 D000483
- 650 _2
- $a substituce aminokyselin $7 D019943
- 650 _2
- $a kohortové studie $7 D015331
- 650 _2
- $a exony $x genetika $7 D005091
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a zárodečné mutace $7 D018095
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a mnohočetná endokrinní neoplazie typ 2A $x genetika $7 D018813
- 650 _2
- $a mnohočetná endokrinní neoplazie typ 2B $x genetika $7 D018814
- 650 _2
- $a rodokmen $7 D010375
- 650 _2
- $a protoonkogenní proteiny c-ret $x chemická syntéza $7 D051096
- 650 _2
- $a nádory štítné žlázy $x genetika $7 D013964
- 700 1_
- $a Václavíková, Eliška. $7 xx0228492
- 700 1_
- $a Ryška, Aleš, $d 1970- $7 nlk20020124969
- 700 1_
- $a Čáp, Jan, $d 1953- $7 mzk2003190513
- 700 1_
- $a Vlček, Petr, $d 1961- $7 xx0003505
- 700 1_
- $a Dušková, Jana. $7 _AN030766
- 700 1_
- $a Nováková Kodetová, Daniela, $d 1953- $7 jo2002104665
- 700 1_
- $a Holub, Václav, $d 1952- $7 mzk2003181804
- 700 1_
- $a Novák, Zdeněk, $d 1953- $7 jo20000074101
- 700 1_
- $a Bendlová, Běla, $d 1962- $7 jo20000074069
- 773 0_
- $w MED00009707 $t Experimental and clinical endocrinology & diabetes $g Roč. 114, č. 4 (2006), s. 192-196 $x 0947-7349
- 910 __
- $a ABA008 $b x $y 9
- 990 __
- $a 20090506084234 $b ABA008
- 991 __
- $a 20130819124827 $b ABA008
- 999 __
- $a ok $b bmc $g 656639 $s 509955
- BAS __
- $a 3
- BMC __
- $a 2006 $b 114 $c 4 $d 192-196 $i 0947-7349 $m Experimental and clinical endocrinology & diabetes $x MED00009707 $n Exp Clin Endocrinol Diabetes
- GRA __
- $a NR7806 $p MZ0
- LZP __
- $a 2009-B2/vtme